SCHEDULE 13G: Investment Group Discloses 4.99% Stake in Jaguar Health, Inc. Following Securities Purchase Agreement

Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC have jointly disclosed a 4.99% beneficial ownership stake in Jaguar Health, Inc. as of May 27, 2025, stemming from a recent Securities Purchase Agreement.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have filed a Schedule 13G disclosing their beneficial ownership in Jaguar Health, Inc.
• As of May 27, 2025, the Reporting Persons collectively beneficially own 65,002 shares of Jaguar Health, Inc. common stock.
• This ownership represents approximately 4.99% of the company's common stock.
• The 65,002 shares consist of 27,000 shares held directly by Intracoastal Capital LLC and 38,002 shares issuable upon exercise of Intracoastal Warrant 1.
• The calculation of the 4.99% ownership is based on 1,018,352 shares outstanding as of May 20, 2025, plus 246,306 shares issued at the closing of the Securities Purchase Agreement (SPA), and the 38,002 shares from Intracoastal Warrant 1.
• Immediately following the execution of the SPA on May 20, 2025, the Reporting Persons were deemed to have beneficial ownership of 82,102 shares, representing approximately 7.5% of the common stock, prior to the application of blocker provisions.
• The beneficial ownership calculation excludes additional shares from Intracoastal Warrant 1 (126,202 shares) and Intracoastal Warrant 2 (45,168 shares) due to blocker provisions that prevent ownership from exceeding 4.99%.
• Without these blocker provisions, the Reporting Persons would have been deemed to beneficially own 236,372 shares as of May 27, 2025, and 291,474 shares immediately following the SPA on May 20, 2025.
• The Reporting Persons share voting power over 65,002 shares and shared dispositive power over 58,402 shares.
• The acquisition of these securities was not for the purpose of changing or influencing control of Jaguar Health, Inc., other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: A Schedule 13G is a neutral, factual disclosure of beneficial ownership. It does not inherently convey positive or negative sentiment about the company's performance, though the act of an investment group taking a stake can be seen as a minor positive signal.

Positives

• The filing indicates a new investment group, Intracoastal Capital LLC, and its principals have taken a significant stake in Jaguar Health, Inc., potentially signaling confidence in the company.
• The investment stems from a Securities Purchase Agreement, suggesting a recent capital infusion into Jaguar Health, Inc.

Negatives

• The presence of "blocker provisions" in the warrants, which limit beneficial ownership to 4.99%, suggests that the investors are intentionally avoiding crossing the 5% threshold that would trigger more extensive reporting requirements (e.g., Schedule 13D, which implies intent to influence or control). This could be interpreted as a passive investment rather than an active, long-term strategic commitment to influence company direction.

Risks

• NA

Future Outlook

NA

Industry Context

This Schedule 13G filing indicates a new significant investor group has taken a stake in Jaguar Health, Inc. Such filings are common in the financial industry as part of regulatory disclosure requirements when an entity or group acquires a certain percentage of a public company's shares. The presence of blocker provisions in warrants is a common strategy for investors to manage their beneficial ownership percentage to stay below thresholds that trigger more stringent reporting or regulatory scrutiny, such as the 5% threshold for Schedule 13D filings.

Comparison to Industry Standards

• NA

Related Party Transactions

• The Securities Purchase Agreement (SPA) between Jaguar Health, Inc. and Intracoastal Capital LLC (and its principals) represents a transaction between the issuer and a significant investor. While not explicitly labeled "related party" in the document, it is a direct transaction involving the issuance of securities to a party that becomes a significant shareholder.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant ownership stake held by an investment group. The issuance of new shares under the SPA could lead to dilution for existing shareholders, although the exact impact depends on the terms of the SPA and the total shares outstanding. The presence of a new investor group might be viewed positively as a sign of confidence or negatively if it implies future dilution or a passive investment strategy.
• Company Management: Awareness of a significant shareholder group, even a passive one, can influence management's strategic decisions and communication.

Next Steps

• The Reporting Persons will be responsible for timely filing of subsequent amendments to this Schedule 13G.

Key Dates

Keywords

Jaguar Health Inc, Schedule 13G, beneficial ownership, Mitchell P. Kopin, Daniel B. Asher, Intracoastal Capital LLC, common stock, SEC filing, investment, equity stake, securities purchase agreement, warrants